Skip to content
NYSE · X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS · SMALL CAP

Butterfly Network, Inc. BFLY

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$97.6M
▲ 19.0% YoY
$-77.1M
$-16.0M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

The company markets and sells the Butterfly solution to healthcare systems, physicians and healthcare providers through a direct sales force, distributors and its eCommerce channel. The company's ultrasound devices fit in a healthcare professional's pocket and pair with cloud-connected software accessed through a mobile application. Butterfly iQ3 is currently FDA-cleared for sale in the United States and CE marked in Europe. The company generated total revenue of $97.6 million for the year ended December 31, 2025. Butterfly employed approximately 220 employees as of January 31, 2026, and sold its products in over 30 countries. The Company, formerly known as Longview Acquisition Corp., was incorporated in Delaware in 2020 as a blank check company. Butterfly Network, Inc., previously Legacy Butterfly, was founded in 2011 and completed a business combination with Longview on February 12, 2021, after which Longview was renamed Butterfly Network, Inc.

Written from the business description in Butterfly Network, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth

USD 97.6M
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 97.6 · Net income -77.1
40M80M-100M-200M
201920222025
Compound annual growth
+10.0%
+16.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +16.1% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−79 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -88.5% · Net -79.0%
-100%-200%-300%
201920222025
ROE
FY2025 · ROE -42.2%
-20%-40%
201920222025
Three returns, three denominators.

Each USD of equity lost 42 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -16.0
-100M-200M
201920222025

Total assetsUSD 296.5M
EquityUSD 196.0M
CashUSD 150.5M
Current ratio3.83×

Equity funds 66% of total assets.

The 7-year record

7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
BFLY, 7-year financial record
Metric 2025202420232022202120202019
Revenue $B0.10.10.10.10.10.00.0
Operating income $B−0.1−0.1−0.1−0.2−0.2−0.2−0.1
EBITDA $B−0.1−0.1−0.1−0.2−0.2−0.2−0.1
Income tax $B0.0−0.00.00.00.00.0◌
Net income $B−0.1−0.1−0.1−0.2−0.0−0.2−0.1
Free cash flow $B−0.0−0.0−0.1−0.2−0.2−0.1−0.1
EPS, diluted $−0.31−0.34−0.65−0.84−0.19−26.87−17.08
Dividend / sh $0.000.000.000.000.00◌◌
Payout % — not applicable: no dividend———————
ROE %−42.2−37.3−49.0−43.7———
Shares out B◌◌◌◌◌◌◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 33 reconciliationsAUDITED

Reconciled in 7 of the 7 fiscal years we could check. 26 checks were skipped: the balance sheet is not tagged before 2020. 12 checks were skipped: EPS is not tagged before 2019. 12 checks were skipped: revenue is not tagged before 2019.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityX-Ray Apparatus & Tubes & Related Irradiation Apparatus
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2018

Share this section

Download image